IHE

iShares U.S. Pharmaceuticals ETF

iShares Dow Jones US Pharmaceuticals Index Fund seeks investment results that correspond to the price and yield of the Dow Jones US Select Pharmaceuticals Index.


US

EQUITY

Passive

MANAGEMENT STYLE

40 bp

EXPENSES

$646.3 M

ASSETS UNDER MGMT

FACTOR SCORECARD

SIZE
VALUE
YIELD
MOMENTUM
VOLATILITY
QUALITY
Fund Basics
Fund sponsorBarclays Global Fund Advisors
CategoryUS
Asset classEquity
Websitelink...
Inception dateMay 01, 2006
Assets (mns)$646
Expense ratio40 bp
CurrencyUSD
Sector Breakdown
Fund Structure
RegulationOpen-Ended Fund
DistributionsQuarterly
Taxation1099
Stock selectionMarket Cap
WeightingMarket Cap
Holdings TransparencyFull
Derivatives-basedNo
Options availableYes
Currency hedgedNo
Fund of fundsNo
Top 10 Holdings Complete list  + 
ELI LILLY & CO 23.9 %
JOHNSON & JOHNSON 22.5 %
VIATRIS, INC. 4.6 %
PFIZER INC 4.6 %
ZOETIS INC 4.4 %
MERCK & CO. INC. 4.3 %
BRISTOL-MYERS SQUIBB CO 4.2 %
CATALENT INC 4.1 %
ROYALTY PHARMA PLC CLASS A 4.1 %
INTRA-CELLULAR THERAPIES INC 3.0 %
Constituent Breakdown
Number of holdings36
Herfindahl-Hirschman Index 1,265
Wgt avg mkt cap (mns)$314,138
Large cap (>$10bn)77.0%
Mid cap ($2-10bn)16.0%
Small cap (<$2bn)7.0%
Developed mkts.100.0%
Emerging mkts.0.0%
Country Exposure
UNITED STATES 95.0 %
IRELAND 4.1 %
Historical Performance


Standardized Performance (as of 06/30/2024)
 YTD1 YR2 YR3 YR5 YR10 YRIncep.
Total Returns 8.2% 13.5% 4.0% 4.3% 7.5% 5.4% 9.8%
Volatility 11.8% 13.4% 14.9% 15.0% 18.4% 18.8% --
Market Correlations
versus...BetaR-squared
S&P 5000.5646%
MSCI EAFE0.5441%
MSCI Emg Mkts0.2912%
Liquidity Measures
Avg. volume (000)103
Turnover1.1%
Avg. Bid/Ask (% of price)0.09%
ADV of underlying (mns)$17,210
Technical Indicators
Recent close$67.68
30d moving avg.$66.00
Annualized volatility14.7%
Relative strength (RSI)54
Short interest (ETF)1.0%
Short interest (underlying)2.8%
Distributions
Assets Under Management (mns)

Money Flows (mns)

Short Interest (as % of shares outstanding)

Long Money Flows (mns)

Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial

Risk and Returns: IHE vs. Comps (1 YR)

Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.

Content on this tab for Individual & Professional subscribers only. Start your FREE trial

Results & Estimates
  2019 2020 2021 2022 2023 2024E 2025E  
Sales per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Earnings per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Dividends per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Book value per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Return on Equity
Net Margins
EPS Revision Activity (6 mo. ago = 100%)
Compound Annual Growth Rates

Content on this tab for Individual & Professional subscribers only. Start your FREE trial

Valuation Metrics
  2023 2024E Fwd Est 2025E
Price-to-sales --x --x --x --x
Price-to-earnings --x --x --x --x
Price-to-cash flow --x --x --x --x
Price-to-growth --x --x --x --x
Price-to-book value --x --x --x --x
Yield --% --% --x --%
3.1 14.6 2.4 2.3% --
Based on closing prices from 7/18/2024
Historical Valuation Trends Sample data. Subscribe for access.

SHOWING:
Price-to-Earnings
IHE



Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.

Some content on this tab for Individual & Professional subscribers only. Start your FREE trial

ETF Research Center Fund Rating

Our measure of an ETF's overall investment merit

ALTAR Score™

IHE

8.3%

Cat. Avg

5.7%

Fund Category: US

Avg. Return on Equity--%
Divided by: Fwd. P/BV--x
Less: Expenses-- bp
Equals: ALTAR Score™8.3%
Recommendation

SPECULATIVE

Deeply undervalued but risky. A rating of SPECULATIVE is assigned to ETFs with ALTAR Scores in the top quintile (the top 20%) of their category, indicating exceptional appreciation potential. However, often these are narrowly-focused funds or in industries with structural issues, which may also make them very risky. Nonetheless they may still be useful as part of a well-diversified portfolio.

Category Overview
There are 899 funds in the US category, with an average ALTAR Score™ of 5.7% and a standard deviation of 2.4%. IHE's ALTAR Score™ is approximately 1.1 standard deviations above the category average. This places IHE in the 86th percentile among funds in the category.
Consensus Recommendation

Sell-side recommendations on the ETF's individual constituents

Composite
IHE
Peer Average
SELL
U/W
HOLD
O/W
BUY



Recent Trends


Breakdown
Expense Analysis

Peer Group Passive
US Equity ETFs
# of ETFs 192
Avg. Expense Ratio 31.0 bp
Std. Deviation 25.7 bp
IHE (40 bp) Percentile rank 64
Peer Group Expense Ratio Distribution


Total Cost of Ownership (TCO) Comparison
Expense (bp)
(A)
Avg. Bid/Ask (bp)
(B)
TCO (bp)
(A)+(B)
IHE 40.0 8.7 48.7
Peer Avg. 29.8 6.8 36.5
  For a detailed cost analysis of this and any other ETF use the TCO Comparison Tool .